IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity

doi:10.1084/jem.183.6.2663

This Article

	Full Text (PDF, 1755K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Lee, M. S.
	Articles by Sarvetnick, N.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Lee, M. S.
	Articles by Sarvetnick, N.


Social Bookmarking

	What's this?

ARTICLES

IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity

MS Lee, R Mueller, LS Wicker, LB Peterson and N Sarvetnick
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California 92037, USA.

Contrary to expectations based on in vitro experiments, we previously found that pancreatic IL-10 did not inhibit autoimmune diabetes but accelerated it in an MHC-dependent manner. Therefore, the ability of IL- 10 to overcome the absence of all non-MHC diabetes susceptibility (Idd) alleles was studied in transgenic mice expressing pancreatic IL-10 backcrossed to B10.H2g7 congenic mice, which have no Idd alleles other than NOD MHC (H2g7). IL-10 transgenic backcross 1 (BC1) mice with H2g7/g7 haplotype developed clear-cut insulitis and diabetes, but neither transgenic mice with the H2g/b haplotype nor nontransgenic BC1 mice did so. Further implicating IL-10 in autoimmune diabetes, anti-IL- 10 antibody treatment inhibited the development of insulitis in NOD mice. These results suggest that IL-10 may be necessary and sufficient for producing autoimmune diabetes in conjunction with NOD MHC homozygosity and that some Idd genes may be related to the regulation of IL-10.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Hussain, S., Delovitch, T. L. (2007). Intravenous Transfusion of BCR-Activated B Cells Protects NOD Mice from Type 1 Diabetes in an IL-10-Dependent Manner. J. Immunol. 179: 7225-7232 [Abstract] [Full Text]
Chamberlain, G., Wallberg, M., Rainbow, D., Hunter, K., Wicker, L. S., Green, E. A. (2006). A 20-Mb Region of Chromosome 4 Controls TNF-{alpha}-Mediated CD8+ T Cell Aggression Toward beta Cells in Type 1 Diabetes. J. Immunol. 177: 5105-5114 [Abstract] [Full Text]
Mekala, D. J., Alli, R. S., Geiger, T. L. (2005). IL-10-Dependent Suppression of Experimental Allergic Encephalomyelitis by Th2-Differentiated, Anti-TCR Redirected T Lymphocytes. J. Immunol. 174: 3789-3797 [Abstract] [Full Text]
Greve, B., Vijayakrishnan, L., Kubal, A., Sobel, R. A., Peterson, L. B., Wicker, L. S., Kuchroo, V. K. (2004). The Diabetes Susceptibility Locus Idd5.1 on Mouse Chromosome 1 Regulates ICOS Expression and Modulates Murine Experimental Autoimmune Encephalomyelitis. J. Immunol. 173: 157-163 [Abstract] [Full Text]
Wicker, L. S., Chamberlain, G., Hunter, K., Rainbow, D., Howlett, S., Tiffen, P., Clark, J., Gonzalez-Munoz, A., Cumiskey, A. M., Rosa, R. L., Howson, J. M., Smink, L. J., Kingsnorth, A., Lyons, P. A., Gregory, S., Rogers, J., Todd, J. A., Peterson, L. B. (2004). Fine Mapping, Gene Content, Comparative Sequencing, and Expression Analyses Support Ctla4 and Nramp1 as Candidates for Idd5.1 and Idd5.2 in the Nonobese Diabetic Mouse. J. Immunol. 173: 164-173 [Abstract] [Full Text]
Mi, Q.-S., Ly, D., Zucker, P., McGarry, M., Delovitch, T. L. (2004). Interleukin-4 but not Interleukin-10 Protects Against Spontaneous and Recurrent Type 1 Diabetes by Activated CD1d-Restricted Invariant Natural Killer T-Cells. Diabetes 53: 1303-1310 [Abstract] [Full Text]
Chen, C., Lee, W.-H., Yun, P., Snow, P., Liu, C.-P. (2003). Induction of Autoantigen-Specific Th2 and Tr1 Regulatory T Cells and Modulation of Autoimmune Diabetes. J. Immunol. 171: 733-744 [Abstract] [Full Text]
Lee, C. G., Homer, R. J., Cohn, L., Link, H., Jung, S., Craft, J. E., Graham, B. S., Johnson, T. R., Elias, J. A. (2002). Transgenic Overexpression of Interleukin (IL)-10 in the Lung Causes Mucus Metaplasia, Tissue Inflammation, and Airway Remodeling via IL-13-dependent and -independent Pathways. J. Biol. Chem. 277: 35466-35474 [Abstract] [Full Text]
Johansson, A. C. M., Hansson, A.-S., Nandakumar, K. S., Backlund, J., Holmdahl, R. (2001). IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies. J. Immunol. 167: 3505-3512 [Abstract] [Full Text]
La Cava, A., Balasa, B., Good, A., van Gunst, K., Jung, N., Sarvetnick, N. (2001). H-2D End Confers Dominant Protection from IL-10-Mediated Acceleration of Autoimmune Diabetes in the Nonobese Diabetic Mouse. J. Immunol. 167: 1066-1071 [Abstract] [Full Text]
Glickstein, L., Edelstein, M., Dong, J. Z. (2001). Gamma Interferon Is Not Required for Arthritis Resistance in the Murine Lyme Disease Model. Infect. Immun. 69: 3737-3743 [Abstract] [Full Text]
Ostlie, N. S., Karachunski, P. I., Wang, W., Monfardini, C., Kronenberg, M., Conti-Fine, B. M. (2001). Transgenic Expression of IL-10 in T Cells Facilitates Development of Experimental Myasthenia Gravis. J. Immunol. 166: 4853-4862 [Abstract] [Full Text]
Gibson, A. W., Edberg, J. C., Wu, J., Westendorp, R. G. J., Huizinga, T. W. J., Kimberly, R. P. (2001). Novel Single Nucleotide Polymorphisms in the Distal IL-10 Promoter Affect IL-10 Production and Enhance the Risk of Systemic Lupus Erythematosus. J. Immunol. 166: 3915-3922 [Abstract] [Full Text]
Balasa, B., La Cava, A., Van Gunst, K., Mocnik, L., Balakrishna, D., Nguyen, N., Tucker, L., Sarvetnick, N. (2000). A Mechanism for IL-10-Mediated Diabetes in the Nonobese Diabetic (NOD) Mouse: ICAM-1 Deficiency Blocks Accelerated Diabetes. J. Immunol. 165: 7330-7337 [Abstract] [Full Text]
Noorchashm, H., Moore, D. J., Noto, L. E., Noorchashm, N., Reed, A. J., Reed, A. L., Song, H. K., Mozaffari, R., Jevnikar, A. M., Barker, C. F., Naji, A. (2000). Impaired CD4 T Cell Activation Due to Reliance Upon B Cell-Mediated Costimulation in Nonobese Diabetic (NOD) Mice. J. Immunol. 165: 4685-4696 [Abstract] [Full Text]
Balasa, B., Van Gunst, K., Jung, N., Balakrishna, D., Santamaria, P., Hanafusa, T., Itoh, N., Sarvetnick, N. (2000). Islet-Specific Expression of IL-10 Promotes Diabetes in Nonobese Diabetic Mice Independent of Fas, Perforin, TNF Receptor-1, and TNF Receptor-2 Molecules. J. Immunol. 165: 2841-2849 [Abstract] [Full Text]
Gallichan, W. S., Balasa, B., Davies, J. D., Sarvetnick, N. (1999). Pancreatic IL-4 Expression Results in Islet-Reactive Th2 Cells That Inhibit Diabetogenic Lymphocytes in the Nonobese Diabetic Mouse. J. Immunol. 163: 1696-1703 [Abstract] [Full Text]
Azar, S. T., Tamim, H., Beyhum, H. N., Habbal, M. Z., Almawi, W. Y. (1999). Type I (Insulin-Dependent) Diabetes Is a Th1- and Th2-Mediated Autoimmune Disease. CVI 6: 306-310 [Full Text]
Almawi, W. Y., Tamim, H., Azar, S. T. (1999). T Helper Type 1 and 2 Cytokines Mediate the Onset and Progression of Type I (Insulin-Dependent) Diabetes. J. Clin. Endocrinol. Metab. 84: 1497-1502 [Abstract] [Full Text]
Saito, I., Haruta, K., Shimuta, M., Inoue, H., Sakurai, H., Yamada, K., Ishimaru, N., Higashiyama, H., Sumida, T., Ishida, H., Suda, T., Noda, T., Hayashi, Y., Tsubota, K. (1999). Fas Ligand-Mediated Exocrinopathy Resembling Sjogren's Syndrome in Mice Transgenic for IL-10. J. Immunol. 162: 2488-2494 [Abstract] [Full Text]
Ridgway, W. M., Ito, H., Fasso, M., Yu, C., Garrison Fathman, C. (1998). Analysis of the Role of Variation of Major Histocompatibility Complex Class II Expression on Nonobese Diabetic (NOD) Peripheral T Cell Response. JEM 188: 2267-2275 [Abstract] [Full Text]
Balasa, B., Davies, J. D., Lee, J., Good, A., Yeung, B. T., Sarvetnick, N. (1998). IL-10 Impacts Autoimmune Diabetes Via a CD8+ T Cell Pathway Circumventing the Requirement for CD4+ T and B Lymphocytes. J. Immunol. 161: 4420-4427 [Abstract] [Full Text]
Falcone, M., Lee, J., Patstone, G., Yeung, B., Sarvetnick, N. (1998). B Lymphocytes Are Crucial Antigen-Presenting Cells in the Pathogenic Autoimmune Response to GAD65 Antigen in Nonobese Diabetic Mice. J. Immunol. 161: 1163-1168 [Abstract] [Full Text]
Tian, J., Lehmann, P. V., Kaufman, D. L. (1997). Determinant Spreading of T Helper Cell 2 (Th2) Responses to Pancreatic Islet Autoantigens. JEM 186: 2039-2043 [Abstract] [Full Text]
Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., McDevitt, H. O. (1997). Chronic Tumor Necrosis Factor Alters T Cell Responses by Attenuating T Cell Receptor Signaling. JEM 185: 1573-1584 [Abstract] [Full Text]